Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $1.39M invested in Bio-Rad Laboratories Class B in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 0.11% → 0.09% (-0.03%)
25% less funds holding
Funds holding: 8 → 6 (-2)
30% less capital invested
Capital invested by funds: $2M → $1.39M (-$606K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$218K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$675K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$17.8K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$10.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $585K | -$10.9K | -36 | -2% |
|
|
2
Morgan Stanley
New York
| $461K | +$218K | +724 | +100% |
|
|
BSW
3
Buckingham Strategic Wealth
Clayton,
Missouri
| $242K | – | – | – |
|
4
Wells Fargo
San Francisco,
California
| $54.5K | – | – | – |
|
|
WT
5
Whittier Trust
South Pasadena,
California
| $50.5K | – | – | – |
|
|
JFA
6
JNBA Financial Advisors
Bloomington,
Minnesota
| $637 | – | – | – |
|
|
7
Renaissance Technologies
New York
| – | -$675K | -1,900 | Closed |
|
|
8
Osaic Holdings
Scottsdale,
Arizona
| – | -$17.8K | -50 | Closed |
|
BIO.B Hedge Fund Activity: Q4 2023 in Review
6 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2023, worth a combined $1.39M — down 30% from $2M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BIO.B and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $218K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $675K sold.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2023, down from 8 in Q3 2023.
- Funds reported $1.39M of Bio-Rad Laboratories Class B stock for Q4 2023, down 30% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q4 2023 and 2 closed out, a net change of -2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2023 was Morgan Stanley, an estimated $218K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2023 was Renaissance Technologies, an estimated $675K sold.
Based on aggregated 13F filings for Q4 2023.